HDAC3 inhibition ameliorates spinal cord injury by immunomodulation

Abstract Following spinal cord injury (SCI), the innate immune response of microglia and infiltrating macrophages clears up cellular debris and promotes tissue repair, but it also inflicts secondary injury from inflammatory responses. Immunomodulation aimed at maximizing the beneficial effects while...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tomoharu Kuboyama, Shalaka Wahane, Yong Huang, Xiang Zhou, Jamie K. Wong, Andrew Koemeter-Cox, Michael Martini, Roland H. Friedel, Hongyan Zou
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a10fe06ffb994a84ac85365b0b75d5d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a10fe06ffb994a84ac85365b0b75d5d1
record_format dspace
spelling oai:doaj.org-article:a10fe06ffb994a84ac85365b0b75d5d12021-12-02T11:52:19ZHDAC3 inhibition ameliorates spinal cord injury by immunomodulation10.1038/s41598-017-08535-42045-2322https://doaj.org/article/a10fe06ffb994a84ac85365b0b75d5d12017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08535-4https://doaj.org/toc/2045-2322Abstract Following spinal cord injury (SCI), the innate immune response of microglia and infiltrating macrophages clears up cellular debris and promotes tissue repair, but it also inflicts secondary injury from inflammatory responses. Immunomodulation aimed at maximizing the beneficial effects while minimizing the detrimental roles of the innate immunity may aid functional recovery after SCI. However, intracellular drivers of global reprogramming of the inflammatory gene networks in the innate immune cells are poorly understood. Here we show that SCI resulted in an upregulation of histone deacetylase 3 (HDAC3) in the innate immune cells at the injury site. Remarkably, blocking HDAC3 with a selective small molecule inhibitor shifted microglia/macrophage responses towards inflammatory suppression, resulting in neuroprotective phenotypes and improved functional recovery in SCI model. Mechanistically, HDAC3 activity is largely responsible for histone deacetylation and inflammatory responses of primary microglia to classic inflammatory stimuli. Our results reveal a novel function of HDAC3 inhibitor in promoting functional recovery after SCI by dampening inflammatory cytokines, thus pointing towards a new direction of immunomodulation for SCI repair.Tomoharu KuboyamaShalaka WahaneYong HuangXiang ZhouJamie K. WongAndrew Koemeter-CoxMichael MartiniRoland H. FriedelHongyan ZouNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tomoharu Kuboyama
Shalaka Wahane
Yong Huang
Xiang Zhou
Jamie K. Wong
Andrew Koemeter-Cox
Michael Martini
Roland H. Friedel
Hongyan Zou
HDAC3 inhibition ameliorates spinal cord injury by immunomodulation
description Abstract Following spinal cord injury (SCI), the innate immune response of microglia and infiltrating macrophages clears up cellular debris and promotes tissue repair, but it also inflicts secondary injury from inflammatory responses. Immunomodulation aimed at maximizing the beneficial effects while minimizing the detrimental roles of the innate immunity may aid functional recovery after SCI. However, intracellular drivers of global reprogramming of the inflammatory gene networks in the innate immune cells are poorly understood. Here we show that SCI resulted in an upregulation of histone deacetylase 3 (HDAC3) in the innate immune cells at the injury site. Remarkably, blocking HDAC3 with a selective small molecule inhibitor shifted microglia/macrophage responses towards inflammatory suppression, resulting in neuroprotective phenotypes and improved functional recovery in SCI model. Mechanistically, HDAC3 activity is largely responsible for histone deacetylation and inflammatory responses of primary microglia to classic inflammatory stimuli. Our results reveal a novel function of HDAC3 inhibitor in promoting functional recovery after SCI by dampening inflammatory cytokines, thus pointing towards a new direction of immunomodulation for SCI repair.
format article
author Tomoharu Kuboyama
Shalaka Wahane
Yong Huang
Xiang Zhou
Jamie K. Wong
Andrew Koemeter-Cox
Michael Martini
Roland H. Friedel
Hongyan Zou
author_facet Tomoharu Kuboyama
Shalaka Wahane
Yong Huang
Xiang Zhou
Jamie K. Wong
Andrew Koemeter-Cox
Michael Martini
Roland H. Friedel
Hongyan Zou
author_sort Tomoharu Kuboyama
title HDAC3 inhibition ameliorates spinal cord injury by immunomodulation
title_short HDAC3 inhibition ameliorates spinal cord injury by immunomodulation
title_full HDAC3 inhibition ameliorates spinal cord injury by immunomodulation
title_fullStr HDAC3 inhibition ameliorates spinal cord injury by immunomodulation
title_full_unstemmed HDAC3 inhibition ameliorates spinal cord injury by immunomodulation
title_sort hdac3 inhibition ameliorates spinal cord injury by immunomodulation
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/a10fe06ffb994a84ac85365b0b75d5d1
work_keys_str_mv AT tomoharukuboyama hdac3inhibitionamelioratesspinalcordinjurybyimmunomodulation
AT shalakawahane hdac3inhibitionamelioratesspinalcordinjurybyimmunomodulation
AT yonghuang hdac3inhibitionamelioratesspinalcordinjurybyimmunomodulation
AT xiangzhou hdac3inhibitionamelioratesspinalcordinjurybyimmunomodulation
AT jamiekwong hdac3inhibitionamelioratesspinalcordinjurybyimmunomodulation
AT andrewkoemetercox hdac3inhibitionamelioratesspinalcordinjurybyimmunomodulation
AT michaelmartini hdac3inhibitionamelioratesspinalcordinjurybyimmunomodulation
AT rolandhfriedel hdac3inhibitionamelioratesspinalcordinjurybyimmunomodulation
AT hongyanzou hdac3inhibitionamelioratesspinalcordinjurybyimmunomodulation
_version_ 1718395121662164992